FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry and concerns method of production of pharmaceutical composition containing N[(1-butyl-4-piperidinyl) methyl]-3,4-dihydro-2n -[1,3]oxazino[3,2]indole-10-carboxamide (SB 207266) piboserod or its pharmaceutically acceptable salt in combination with one or more pharmaceutically acceptable excipients, thus method includes formation of part or whole SB 207266 or its salts in granules by air-stream granulation. In invention there is also pharmaceutical composition offered which can be produced by air-stream granulation and/or which is produced by air-stream granulation. Declared invention enables to improve parameters of finished composition, and also to scale manufacture.
EFFECT: reception of a pharmaceutical composition with the improved parameters and possibility of its scale production process.
75 cl, 16 ex, 2 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
TABLET COMPOSITION COMPRISING CINACALCET HYDROCHLORIDE | 2013 |
|
RU2662562C2 |
ANTITUBERCULAR COMPOSITION COMPRISING RIFAMPICIN, ISONIAZID, ETHAMBUTOL AND PYRAZINAMIDE AND PROCESS FOR PREPARATION THEREOF | 2014 |
|
RU2672879C2 |
GLUCOSAMINE PROLONGED RELEASE DOSAGE FORM | 2011 |
|
RU2521231C2 |
FORM OF PROLONGED VENLAFAXINE HYDROCHLORIDE LIBERATION | 2004 |
|
RU2340331C2 |
NEW COMPOSITION | 2006 |
|
RU2821230C2 |
NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
PHARMACEUTICAL COMPOSITIONS OF KETOROLAC | 2017 |
|
RU2677663C1 |
ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2014 |
|
RU2679448C2 |
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
Authors
Dates
2008-07-27—Published
2003-01-22—Filed